Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- scientific article published on 17 March 2018 (en)
- article scientifique publié en 2018 (fr)
- artículu científicu espublizáu en marzu de 2018 (ast)
- наукова стаття, опублікована 17 березня 2018 (uk)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Ying He
- Michael Meister
- Thomas Muley
- Farshid Dayyani
- Arne Warth
- Hendrik Dienemann
- Felix J Herth
- Marc A Schneider
- Birgit Wehnl
- Vinzent Rolny
- Achim Escherich
- Christa Stolp
|
rdfs:label
| - The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (en)
- The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (nl)
|
skos:prefLabel
| - The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (en)
- The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (nl)
|
name
| - The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (en)
- The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (nl)
|
title
| |
title
| - The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC) (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
volume
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1016/J.LUNGCAN.2018.03.015
|
is about
of | |
is cites work
of | |
is cites work
of | |